Antiviral nucleosides
US7645745B2 · kind B2 · utility
24Cited by
1References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 4, 2007 |
| Grant date | Jan 12, 2010 |
| Priority date | — |
| Expiry date | Sep 3, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having the formula I wherein R1 is as herein defined are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for inhibiting hepatitis replication, processes for making the compounds and synthetic intermediates used in the process
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.